The Government Accountability Office(GAO), a nonpartisan arm of Congress,recently uncovered serious, rampant problemsin a government program that issueddrug cards to Medicare beneficiaries. Thecards were issued by insurance companiesand pharmacy benefit managers(PBMs). The sponsors had contracts withthe federal government, which approvedtheir cards and regulated their operations.
The GAO's report highlighted the followingissues:
In defense of the discount card program,Mark B. McClellan,MD, PhD, administratorof the Centers for Medicare andMedicaid Services, said that the problemshave been addressed and "most submissionsare now accurate."